In
a letter
to the Drug Enforcement Administration (DEA), the American Hospital Association
(AHA) and other key stakeholders urged temporary measures aimed at addressing a
shortage of injectable opioid medications used in hospitals, hospices, and
surgical centers. Manufacturing delays have led to an ongoing shortage,
creating a problem for patients and providers in numerous settings in Indiana
and nationwide. Read more here.